TreeWAS – Variant ID: rs4775031

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
R20.2 Paraesthesia of skin	0.000	0.989	0.011
T39.0 Salicylates	0.010	0.990	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.010	0.990	0.000
I08.0 Disorders of both mitral and aortic valves	0.000	0.990	0.010
T46 Poisoning by agents primarily affecting the cardiovascular system	0.010	0.990	0.000
R20 Disturbances of skin sensation	0.000	0.991	0.009
T46.4 Angiotensin-converting-enzyme inhibitors	0.009	0.991	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.008	0.992	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.008	0.992	0.000
I08.3 Combined disorders of mitral, aortic and tricuspid valves	0.000	0.992	0.008
T36-T50 Poisoning by drugs, medicaments and biological substances	0.008	0.992	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.008	0.992	0.000
I08 Multiple valve diseases	0.000	0.992	0.008
R20.8 Other and unspecified disturbances of skin sensation	0.000	0.992	0.008
T46.1 Calcium-channel blockers	0.008	0.992	0.000
M65.34 Trigger finger-Hand	0.008	0.992	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.007	0.993	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.007	0.993	0.000
I08.2 Disorders of both aortic and tricuspid valves	0.000	0.993	0.007
T45.5 Anticoagulants	0.007	0.993	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.007	0.993	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.007	0.993	0.000
T46.7 Peripheral vasodilators	0.007	0.993	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.007	0.993	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.007	0.993	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.007	0.993	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.007	0.993	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.007	0.993	0.000
R20.0 Anaesthesia of skin	0.000	0.993	0.007
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.006	0.993	0.000
R20.1 Hypoaesthesia of skin	0.000	0.994	0.006
M23.32 Other meniscus derangements (Posterior cruciate ligament or Posterior horn of medial meniscus)	0.006	0.994	0.000
T39.4 Antirheumatics, not elsewhere classified	0.006	0.994	0.000
T39.2 Pyrazolone derivatives	0.006	0.994	0.000
T38.9 Other and unspecified hormone antagonists	0.006	0.994	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.006	0.994	0.000
T38.7 Androgens and anabolic congeners	0.006	0.994	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.006	0.994	0.000
T38.5 Other oestrogens and progestogens	0.006	0.994	0.000
T38.4 Oral contraceptives	0.006	0.994	0.000
T38.2 Antithyroid drugs	0.006	0.994	0.000
T38.0 Glucocorticoids and synthetic analogues	0.006	0.994	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.006	0.994	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.006	0.994	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.006	0.994	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.006	0.994	0.000
I08.9 Multiple valve disease, unspecified	0.000	0.994	0.006
K63.3 Ulcer of intestine	0.006	0.994	0.000
I08.8 Other multiple valve diseases	0.000	0.994	0.006
R20.3 Hyperaesthesia	0.000	0.994	0.006
T45.0 Antiallergic and antiemetic drugs	0.006	0.994	0.000
R23.8 Other and unspecified skin changes	0.000	0.994	0.006
T38.1 Thyroid hormones and substitutes	0.006	0.994	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.006	0.994	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.006	0.994	0.000
K14.8 Other diseases of tongue	0.006	0.994	0.000
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms	0.006	0.994	0.000
T36 Poisoning by systemic antibiotics	0.006	0.994	0.000
F33.1 Recurrent depressive disorder, current episode moderate	0.006	0.994	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.005	0.994	0.000
T45.8 Other primarily systemic and haematological agents	0.005	0.994	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.005	0.994	0.000
T45.6 Fibrinolysis-affecting drugs	0.005	0.994	0.000
T45.4 Iron and its compounds	0.005	0.994	0.000
T45.3 Enzymes, not elsewhere classified	0.005	0.994	0.000
T45.2 Vitamins, not elsewhere classified	0.005	0.994	0.000
T50.8 Diagnostic agents	0.005	0.994	0.000
T50.7 Analeptics and opioid receptor antagonists	0.005	0.994	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.005	0.994	0.000
T50.5 Appetite depressants	0.005	0.994	0.000
T50.4 Drugs affecting uric acid metabolism	0.005	0.994	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.005	0.994	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.005	0.994	0.000
T50.1 Loop [high-ceiling] diuretics	0.005	0.994	0.000
T50.0 Mineralocorticoids and their antagonists	0.005	0.994	0.000
R23 Other skin changes	0.000	0.994	0.006
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.005	0.995	0.000
F33 Recurrent depressive disorder	0.005	0.995	0.000
R23.4 Changes in skin texture	0.000	0.995	0.005
F60.3 Emotionally unstable personality disorder	0.005	0.995	0.000
Y43.3 Other antineoplastic drugs	0.005	0.995	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.005	0.995	0.000
F60.7 Dependent personality disorder	0.005	0.995	0.000
F60 Specific personality disorders	0.005	0.995	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.005	0.995	0.000
M07.39 Other psoriatic arthropathies (Site unspecified)	0.000	0.995	0.005
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.005	0.995	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.005	0.995	0.000
T39.1 4-Aminophenol derivatives	0.005	0.995	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.004	0.995	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.004	0.995	0.000
T37.5 Antiviral drugs	0.004	0.995	0.000
T37.4 Anthelminthics	0.004	0.995	0.000
T37.3 Other antiprotozoal drugs	0.004	0.995	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.004	0.995	0.000
T37.1 Antimycobacterial drugs	0.004	0.995	0.000
T37.0 Sulphonamides	0.004	0.995	0.000
T41.5 Therapeutic gases	0.004	0.995	0.000
T41.4 Anaesthetic, unspecified	0.004	0.995	0.000
T41.3 Local anaesthetics	0.004	0.995	0.000
T41.2 Other and unspecified general anaesthetics	0.004	0.995	0.000
T41.1 Intravenous anaesthetics	0.004	0.995	0.000
T41.0 Inhaled anaesthetics	0.004	0.995	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.004	0.995	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.004	0.995	0.000
T48.5 Anti-common-cold drugs	0.004	0.995	0.000
T48.4 Expectorants	0.004	0.995	0.000
T48.3 Antitussives	0.004	0.995	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.004	0.995	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.004	0.995	0.000
T48.0 Oxytocic drugs	0.004	0.995	0.000
T49.9 Topical agent, unspecified	0.004	0.995	0.000
T49.8 Other topical agents	0.004	0.995	0.000
T49.7 Dental drugs, topically applied	0.004	0.995	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.004	0.995	0.000
T49.5 Ophthalmological drugs and preparations	0.004	0.995	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.004	0.995	0.000
T49.3 Emollients, demulcents and protectants	0.004	0.995	0.000
T49.2 Local astringents and local detergents	0.004	0.995	0.000
T49.1 Antipruritics	0.004	0.995	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.004	0.995	0.000
R20-R23 Symptoms and signs involving the skin and subcutaneous tissue	0.000	0.995	0.005
R23.1 Pallor	0.000	0.996	0.004
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.004	0.996	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.004	0.996	0.000
T47.7 Emetics	0.004	0.996	0.000
T47.6 Antidiarrhoeal drugs	0.004	0.996	0.000
T47.5 Digestants	0.004	0.996	0.000
T47.4 Other laxatives	0.004	0.996	0.000
T47.3 Saline and osmotic laxatives	0.004	0.996	0.000
T47.2 Stimulant laxatives	0.004	0.996	0.000
T47.0 Histamine H(2)-receptor antagonists	0.004	0.996	0.000
R23.2 Flushing	0.000	0.996	0.004
T36.9 Systemic antibiotic, unspecified	0.004	0.996	0.000
T36.8 Other systemic antibiotics	0.004	0.996	0.000
T36.7 Antifungal antibiotics, systemically used	0.004	0.996	0.000
T36.6 Rifamycins	0.004	0.996	0.000
T36.5 Aminoglycosides	0.004	0.996	0.000
T36.4 Tetracyclines	0.004	0.996	0.000
T36.3 Macrolides	0.004	0.996	0.000
T36.2 Chloramphenicol group	0.004	0.996	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.004	0.996	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.004	0.996	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.004	0.996	0.000
R23.0 Cyanosis	0.000	0.996	0.004
H26.4 After-cataract	0.004	0.996	0.000
H53.1 Subjective visual disturbances	0.004	0.996	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.004	0.996	0.000
F33.0 Recurrent depressive disorder, current episode mild	0.004	0.996	0.000
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.004	0.996	0.000
F60.8 Other specific personality disorders	0.004	0.996	0.000
M65.3 Trigger finger	0.004	0.996	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.004	0.996	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.004	0.996	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.004	0.996	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.004	0.996	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.004	0.996	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.004	0.996	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.004	0.996	0.000
T44.0 Anticholinesterase agents	0.004	0.996	0.000
F60.6 Anxious [avoidant] personality disorder	0.004	0.996	0.000
F33.8 Other recurrent depressive disorders	0.004	0.996	0.000
F33.4 Recurrent depressive disorder, currently in remission	0.004	0.996	0.000
T36.0 Penicillins	0.004	0.996	0.000
K10.8 Other specified diseases of jaws	0.004	0.996	0.000
N81.3 Complete uterovaginal prolapse	0.004	0.996	0.000
I08.1 Disorders of both mitral and tricuspid valves	0.000	0.996	0.004
F33.9 Recurrent depressive disorder, unspecified	0.004	0.996	0.000
F60.5 Anankastic personality disorder	0.004	0.996	0.000
F60.4 Histrionic personality disorder	0.004	0.996	0.000
F60.2 Dissocial personality disorder	0.004	0.996	0.000
F60.1 Schizoid personality disorder	0.004	0.996	0.000
F60.0 Paranoid personality disorder	0.004	0.996	0.000
Y95 Nosocomial condition	0.004	0.996	0.000
F60.9 Personality disorder, unspecified	0.004	0.996	0.000
H53.0 Amblyopia ex anopsia	0.004	0.996	0.000
H53 Visual disturbances	0.004	0.996	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.004	0.996	0.000
R22.4 Localised swelling, mass and lump, lower limb	0.000	0.996	0.004
T43.9 Psychotropic drug, unspecified	0.004	0.996	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.004	0.996	0.000
F81.9 Developmental disorder of scholastic skills, unspecified	0.004	0.996	0.000
T43.6 Psychostimulants with abuse potential	0.003	0.996	0.000
H53.2 Diplopia	0.004	0.996	0.000
C90.0 Multiple myeloma	0.003	0.997	0.000
M07.3 Other psoriatic arthropathies	0.000	0.997	0.003
F60-F69 Disorders of adult personality and behaviour	0.003	0.997	0.000
S32.50 Fracture of pubis (closed)	0.000	0.997	0.003
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.003	0.997	0.000
T40.8 Lysergide [LSD]	0.003	0.997	0.000
T40.7 Cannabis (derivatives)	0.003	0.997	0.000
T40.5 Cocaine	0.003	0.997	0.000
T40.3 Methadone	0.003	0.997	0.000
T40.1 Heroin	0.003	0.997	0.000
T40.0 Opium	0.003	0.997	0.000
T40.6 Other and unspecified narcotics	0.003	0.997	0.000
H53.8 Other visual disturbances	0.003	0.997	0.000
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.003	0.997	0.000
M65.39 Trigger finger-Site unspec	0.003	0.997	0.000
M65.38 Trigger finger-Other	0.003	0.997	0.000
M65.37 Trigger finger-Ankle/foot	0.003	0.997	0.000
M65.36 Trigger finger-Lower leg	0.003	0.997	0.000
M65.35 Trigger finger-Pelvic/thigh	0.003	0.997	0.000
M65.33 Trigger finger-Forearm	0.003	0.997	0.000
M65.32 Trigger finger-Upper arm	0.003	0.997	0.000
M65.31 Trigger finger-Shldr region	0.003	0.997	0.000
M65.30 Trigger finger-Mult sites	0.003	0.997	0.000
E86 Volume depletion	0.003	0.997	0.000
R23.3 Spontaneous ecchymoses	0.000	0.997	0.003
F40.2 Specific (isolated) phobias	0.003	0.997	0.000
F81 Specific developmental disorders of scholastic skills	0.003	0.997	0.000
M07.36 Other psoriatic arthropathies (Lower leg)	0.000	0.997	0.003
T43.2 Other and unspecified antidepressants	0.003	0.997	0.000
C90.2 Plasmacytoma, extramedullary	0.003	0.997	0.000
H53.6 Night blindness	0.003	0.997	0.000
H53.5 Colour vision deficiencies	0.003	0.997	0.000
H53.3 Other disorders of binocular vision	0.003	0.997	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.003	0.997	0.000
M07.30 Other psoriatic arthropathies (Multiple sites)	0.000	0.997	0.003
H53.4 Visual field defects	0.003	0.997	0.000
R22.0 Localised swelling, mass and lump, head	0.000	0.997	0.003
T40.2 Other opioids	0.003	0.997	0.000
F69 Unspecified disorder of adult personality and behaviour	0.003	0.997	0.000
M43.16 Spondylolisthesis (Lumbar region)	0.000	0.997	0.003
R22 Localised swelling, mass and lump of skin and subcutaneous tissue	0.000	0.997	0.003
F10.2 Dependence syndrome	0.003	0.997	0.000
M07.38 Other psoriatic arthropathies (Other)	0.000	0.997	0.003
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.000	0.997	0.003
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)	0.000	0.997	0.003
M07.34 Other psoriatic arthropathies (Hand)	0.000	0.997	0.003
M07.33 Other psoriatic arthropathies (Forearm)	0.000	0.997	0.003
M07.32 Other psoriatic arthropathies (Upper arm)	0.000	0.997	0.003
M07.31 Other psoriatic arthropathies (Shoulder region)	0.000	0.997	0.003
F80-F89 Disorders of psychological development	0.003	0.997	0.000
F68 Other disorders of adult personality and behaviour	0.003	0.997	0.000
F66 Psychological and behavioural disorders associated with sexual development and orientation	0.003	0.997	0.000
F65 Disorders of sexual preference	0.003	0.997	0.000
F63 Habit and impulse disorders	0.003	0.997	0.000
F62 Enduring personality changes, not attributable to brain damage and disease	0.003	0.997	0.000
F61 Mixed and other personality disorders	0.003	0.997	0.000
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.000	0.997	0.003
C90 Multiple myeloma and malignant plasma cell neoplasms	0.003	0.997	0.000
K14 Diseases of tongue	0.003	0.997	0.000
R30.0 Dysuria	0.000	0.997	0.003
T43.3 Phenothiazine antipsychotics and neuroleptics	0.002	0.997	0.000
K14.6 Glossodynia	0.003	0.997	0.000
L40.5 Arthropathic psoriasis	0.000	0.997	0.003
F64 Gender identity disorders	0.002	0.997	0.000
E27.1 Primary adrenocortical insufficiency	0.000	0.997	0.003
T40.4 Other synthetic narcotics	0.002	0.997	0.000
F81.8 Other developmental disorders of scholastic skills	0.002	0.997	0.000
F81.3 Mixed disorder of scholastic skills	0.002	0.997	0.000
F81.2 Specific disorder of arithmetical skills	0.002	0.997	0.000
F81.1 Specific spelling disorder	0.002	0.997	0.000
F81.0 Specific reading disorder	0.002	0.997	0.000
H47.0 Disorders of optic nerve, not elsewhere classified	0.002	0.997	0.000
Z88.3 Personal history of allergy to other anti-infective agents	0.000	0.997	0.003
F80 Specific developmental disorders of speech and language	0.002	0.998	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.002	0.998	0.000
F40 Phobic anxiety disorders	0.002	0.998	0.000
H47.3 Other disorders of optic disk	0.002	0.998	0.000
V49.5 Passenger injured in collision with other and unspecified motor vehicles in traffic accident	0.002	0.998	0.000
F84 Pervasive developmental disorders	0.002	0.998	0.000
C90.3 Solitary plasmacytoma	0.002	0.998	0.000
H47 Other disorders of optic [2nd] nerve and visual pathways	0.002	0.998	0.000
J32.9 Chronic sinusitis, unspecified	0.002	0.998	0.000
N94.1 Dyspareunia	0.000	0.998	0.002
W49.0 Home	0.002	0.998	0.000
F80.1 Expressive language disorder	0.002	0.998	0.000
X78.0 Home	0.002	0.998	0.000
F89 Unspecified disorder of psychological development	0.002	0.998	0.000
F88 Other disorders of psychological development	0.002	0.998	0.000
F83 Mixed specific developmental disorders	0.002	0.998	0.000
F82 Specific developmental disorder of motor function	0.002	0.998	0.000
F62.9 Enduring personality change, unspecified	0.002	0.998	0.000
F62.8 Other enduring personality changes	0.002	0.998	0.000
F62.1 Enduring personality change after psychiatric illness	0.002	0.998	0.000
F62.0 Enduring personality change after catastrophic experience	0.002	0.998	0.000
F63.9 Habit and impulse disorder, unspecified	0.002	0.998	0.000
F63.8 Other habit and impulse disorders	0.002	0.998	0.000
F63.3 Trichotillomania	0.002	0.998	0.000
F63.2 Pathological stealing [kleptomania]	0.002	0.998	0.000
F63.1 Pathological fire-setting [pyromania]	0.002	0.998	0.000
F63.0 Pathological gambling	0.002	0.998	0.000
F65.9 Disorder of sexual preference, unspecified	0.002	0.998	0.000
F65.8 Other disorders of sexual preference	0.002	0.998	0.000
F65.6 Multiple disorders of sexual preference	0.002	0.998	0.000
F65.5 Sadomasochism	0.002	0.998	0.000
F65.4 Paedophilia	0.002	0.998	0.000
F65.3 Voyeurism	0.002	0.998	0.000
F65.2 Exhibitionism	0.002	0.998	0.000
F65.1 Fetishistic transvestism	0.002	0.998	0.000
F65.0 Fetishism	0.002	0.998	0.000
F66.9 Psychosexual development disorder, unspecified	0.002	0.998	0.000
F66.8 Other psychosexual development disorders	0.002	0.998	0.000
F66.2 Sexual relationship disorder	0.002	0.998	0.000
F66.1 Egodystonic sexual orientation	0.002	0.998	0.000
F66.0 Sexual maturation disorder	0.002	0.998	0.000
F68.8 Other specified disorders of adult personality and behaviour	0.002	0.998	0.000
F68.1 Intentional production or feigning of symptoms or disabilities, either physical or psychological [factitious disorder]	0.002	0.998	0.000
F68.0 Elaboration of physical symptoms for psychological reasons	0.002	0.998	0.000
C90.1 Plasma cell leukaemia	0.002	0.998	0.000
F40.0 Agoraphobia	0.002	0.998	0.000
R22.7 Localised swelling, mass and lump, multiple sites	0.000	0.998	0.002
K14.5 Plicated tongue	0.002	0.998	0.000
K14.4 Atrophy of tongue papillae	0.002	0.998	0.000
K14.3 Hypertrophy of tongue papillae	0.002	0.998	0.000
K14.2 Median rhomboid glossitis	0.002	0.998	0.000
K14.1 Geographic tongue	0.002	0.998	0.000
F64.9 Gender identity disorder, unspecified	0.002	0.998	0.000
F64.8 Other gender identity disorders	0.002	0.998	0.000
F64.2 Gender identity disorder of childhood	0.002	0.998	0.000
F64.1 Dual-role transvestism	0.002	0.998	0.000
V49.4 Driver injured in collision with other and unspecified motor vehicles in traffic accident	0.002	0.998	0.000
F30-F39 Mood [affective] disorders	0.002	0.998	0.000
Z37.0 Single live birth	0.000	0.998	0.002
F84.5 Asperger's syndrome	0.002	0.998	0.000
K11.5 Sialolithiasis	0.002	0.998	0.000
D51.9 Vitamin B12 deficiency anaemia, unspecified	0.000	0.998	0.002
H47.2 Optic atrophy	0.002	0.998	0.000
N60.3 Fibrosclerosis of breast	0.002	0.998	0.000
M77.47 Metatarsalgia-Ankle/Foot	0.000	0.998	0.002
Chapter V Mental and behavioural disorders	0.002	0.998	0.000
K10 Other diseases of jaws	0.002	0.998	0.000
F80.9 Developmental disorder of speech and language, unspecified	0.002	0.998	0.000
F80.8 Other developmental disorders of speech and language	0.002	0.998	0.000
F80.3 Acquired aphasia with epilepsy [Landau-Kleffner]	0.002	0.998	0.000
F80.2 Receptive language disorder	0.002	0.998	0.000
F80.0 Specific speech articulation disorder	0.002	0.998	0.000
G12.2 Motor neuron disease	0.002	0.998	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.002	0.998	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.002	0.998	0.000
T42.3 Barbiturates	0.002	0.998	0.000
T42.2 Succinimides and oxazolidinediones	0.002	0.998	0.000
V49 Car occupant injured in other and unspecified transport accidents	0.002	0.998	0.000
F40.9 Phobic anxiety disorder, unspecified	0.002	0.998	0.000
F40.8 Other phobic anxiety disorders	0.002	0.998	0.000
F40.1 Social phobias	0.002	0.998	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.002	0.998	0.000
B00.1 Herpesviral vesicular dermatitis	0.002	0.998	0.000
F64.0 Transsexualism	0.002	0.998	0.000
K11.1 Hypertrophy of salivary gland	0.002	0.998	0.000
W49 Exposure to other and unspecified inanimate mechanical forces	0.002	0.998	0.000
F84.9 Pervasive developmental disorder, unspecified	0.002	0.998	0.000
F84.8 Other pervasive developmental disorders	0.002	0.998	0.000
F84.4 Overactive disorder associated with mental retardation and stereotyped movements	0.002	0.998	0.000
F84.3 Other childhood disintegrative disorder	0.002	0.998	0.000
F84.2 Rett's syndrome	0.002	0.998	0.000
F84.1 Atypical autism	0.002	0.998	0.000
F84.0 Childhood autism	0.002	0.998	0.000
S32.5 Fracture of pubis	0.000	0.998	0.002
M94.88 Other specified disorders of cartilage (Other)	0.002	0.998	0.000
H02.0 Entropion and trichiasis of eyelid	0.002	0.998	0.000
H47.7 Disorder of visual pathways, unspecified	0.002	0.998	0.000
H47.6 Disorders of visual cortex	0.002	0.998	0.000
H47.5 Disorders of other visual pathways	0.002	0.998	0.000
H47.4 Disorders of optic chiasm	0.002	0.998	0.000
K11.7 Disturbances of salivary secretion	0.002	0.998	0.000
W49.9 Unspecified place	0.002	0.998	0.000
K11.6 Mucocele of salivary gland	0.002	0.998	0.000
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.002	0.998	0.000
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere	0.002	0.998	0.000
F51.0 Nonorganic insomnia	0.002	0.998	0.000
H47.1 Papilloedema, unspecified	0.002	0.998	0.000
T42.0 Hydantoin derivatives	0.002	0.998	0.000
F51 Nonorganic sleep disorders	0.002	0.998	0.000
S82.10 Fracture of upper end of tibia (closed)	0.000	0.998	0.002
I11.9 Hypertensive heart disease without (congestive) heart failure	0.002	0.998	0.000
M92.6 Juvenile osteochondrosis of tarsus	0.002	0.998	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.002	0.998	0.000
F12.1 Harmful use	0.002	0.998	0.000
I85.0 Oesophageal varices with bleeding	0.002	0.998	0.000
K10.2 Inflammatory conditions of jaws	0.002	0.998	0.000
K14.9 Disease of tongue, unspecified	0.002	0.998	0.000
X78 Intentional self-harm by sharp object	0.002	0.998	0.000
Y43 Primarily systemic agents	0.002	0.998	0.000
O26.9 Pregnancy-related condition, unspecified	0.000	0.998	0.002
F38 Other mood [affective] disorders	0.002	0.998	0.000
I05-I09 Chronic rheumatic heart diseases	0.000	0.998	0.002
K14.0 Glossitis	0.002	0.998	0.000
H53-H54 Visual disturbances and blindness	0.002	0.998	0.000
K10.0 Developmental disorders of jaws	0.002	0.998	0.000
Y85.9 Sequelae of other and unspecified transport accidents	0.000	0.998	0.002
F39 Unspecified mood [affective] disorder	0.002	0.998	0.000
H18 Other disorders of cornea	0.002	0.998	0.000
K11 Diseases of salivary glands	0.002	0.998	0.000
H18.9 Disorder of cornea, unspecified	0.002	0.998	0.000
T42.1 Iminostilbenes	0.002	0.998	0.000
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.002	0.998	0.000
F70-F79 Mental retardation	0.002	0.998	0.000
H35.0 Background retinopathy and retinal vascular changes	0.002	0.998	0.000
K10.9 Disease of jaws, unspecified	0.002	0.998	0.000
K10.3 Alveolitis of jaws	0.002	0.998	0.000
K10.1 Giant cell granuloma, central	0.002	0.998	0.000
V49.8 Car occupant [any] injured in other specified transport accidents	0.002	0.998	0.000
V49.6 Unspecified car occupant injured in collision with other and unspecified motor vehicles in traffic accident	0.002	0.998	0.000
V49.3 Car occupant [any] injured in unspecified nontraffic accident	0.002	0.998	0.000
V49.2 Unspecified car occupant injured in collision with other and unspecified motor vehicles in nontraffic accident	0.002	0.998	0.000
V49.1 Passenger injured in collision with other and unspecified motor vehicles in nontraffic accident	0.002	0.998	0.000
V49.0 Driver injured in collision with other and unspecified motor vehicles in nontraffic accident	0.002	0.998	0.000
R22.9 Localised swelling, mass and lump, unspecified	0.000	0.998	0.002
F44.0 Dissociative amnesia	0.002	0.998	0.000
N88.8 Other specified noninflammatory disorders of cervix uteri	0.002	0.998	0.000
W49.8 Other specified place	0.002	0.998	0.000
W49.7 Farm	0.002	0.998	0.000
W49.6 Industrial and construction area	0.002	0.998	0.000
W49.5 Trade and service area	0.002	0.998	0.000
W49.4 Street and highway	0.002	0.998	0.000
W49.3 Sports and athletics area	0.002	0.998	0.000
W49.2 School, other institution and public administrative area	0.002	0.998	0.000
W49.1 Residential institution	0.002	0.998	0.000
F44 Dissociative [conversion] disorders	0.002	0.998	0.000
S32.51 Fracture of pubis (open)	0.000	0.998	0.002
F34 Persistent mood [affective] disorders	0.002	0.998	0.000
F52 Sexual dysfunction, not caused by organic disorder or disease	0.002	0.998	0.000
D04.6 Skin of upper limb, including shoulder	0.002	0.998	0.000
O21.1 Hyperemesis gravidarum with metabolic disturbance	0.002	0.998	0.000
Y90 Evidence of alcohol involvement determined by blood alcohol level	0.002	0.998	0.000
Y98 Lifestyle-related condition	0.002	0.998	0.000
Y97 Environmental-pollution-related condition	0.002	0.998	0.000
Y96 Work-related condition	0.002	0.998	0.000
H18.5 Hereditary corneal dystrophies	0.002	0.998	0.000
F53 Mental and behavioural disorders associated with the puerperium, not elsewhere classified	0.001	0.998	0.000
F59 Unspecified behavioural syndromes associated with physiological disturbances and physical factors	0.001	0.998	0.000
F55 Abuse of non-dependence-producing substances	0.001	0.998	0.000
F54 Psychological and behavioural factors associated with disorders or diseases classified elsewhere	0.001	0.998	0.000
M07 Psoriatic and enteropathic arthropathies	0.000	0.998	0.002
F44.5 Dissociative convulsions	0.002	0.998	0.000
F51.9 Nonorganic sleep disorder, unspecified	0.001	0.998	0.000
F51.8 Other nonorganic sleep disorders	0.001	0.998	0.000
F51.5 Nightmares	0.001	0.998	0.000
F51.4 Sleep terrors [night terrors]	0.001	0.998	0.000
F51.3 Sleepwalking [somnambulism]	0.001	0.998	0.000
F51.2 Nonorganic disorder of the sleep-wake schedule	0.001	0.998	0.000
F51.1 Nonorganic hypersomnia	0.001	0.998	0.000
H18.4 Corneal degeneration	0.002	0.998	0.000
H18.2 Other corneal oedema	0.002	0.998	0.000
H20.0 Acute and subacute iridocyclitis	0.002	0.998	0.000
T81.7 Vascular complications following a procedure, not elsewhere classified	0.002	0.998	0.000
W22.9 Unspecified place	0.002	0.998	0.000
F40-F48 Neurotic, stress-related and somatoform disorders	0.002	0.998	0.000
H33.0 Retinal detachment with retinal break	0.002	0.998	0.000
Y85.0 Sequelae of motor-vehicle accident	0.000	0.998	0.002
V49.9 Car occupant [any] injured in unspecified traffic accident	0.001	0.998	0.000
F38.8 Other specified mood [affective] disorders	0.001	0.998	0.000
F38.1 Other recurrent mood [affective] disorders	0.001	0.998	0.000
F38.0 Other single mood [affective] disorders	0.001	0.998	0.000
X78.9 Unspecified place	0.001	0.998	0.000
X78.8 Other specified place	0.001	0.998	0.000
X78.7 Farm	0.001	0.998	0.000
X78.6 Industrial and construction area	0.001	0.998	0.000
X78.5 Trade and service area	0.001	0.998	0.000
X78.4 Street and highway	0.001	0.998	0.000
X78.3 Sports and athletics area	0.001	0.998	0.000
X78.2 School, other institution and public administrative area	0.001	0.998	0.000
X78.1 Residential institution	0.001	0.998	0.000
Y43.9 Primarily systemic agent, unspecified	0.001	0.998	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.001	0.998	0.000
Y43.6 Enzymes, not elsewhere classified	0.001	0.998	0.000
Y43.5 Acidifying and alkalising agents	0.001	0.998	0.000
Y43.2 Antineoplastic natural products	0.001	0.998	0.000
I06 Rheumatic aortic valve diseases	0.000	0.998	0.001
H18.1 Bullous keratopathy	0.001	0.998	0.000
H20 Iridocyclitis	0.002	0.998	0.000
I09 Other rheumatic heart diseases	0.000	0.998	0.001
W22 Striking against or struck by other objects	0.002	0.998	0.000
F32.0 Mild depressive episode	0.002	0.998	0.000
H18.7 Other corneal deformities	0.001	0.998	0.000
H18.3 Changes in corneal membranes	0.001	0.998	0.000
H18.0 Corneal pigmentations and deposits	0.001	0.998	0.000
K11.4 Fistula of salivary gland	0.001	0.998	0.000
K11.3 Abscess of salivary gland	0.001	0.998	0.000
K11.0 Atrophy of salivary gland	0.001	0.998	0.000
K81.0 Acute cholecystitis	0.000	0.998	0.002
X62.9 Unspecified place	0.002	0.998	0.000
F78 Other mental retardation	0.001	0.998	0.000
F73 Profound mental retardation	0.001	0.998	0.000
F72 Severe mental retardation	0.001	0.998	0.000
F71 Moderate mental retardation	0.001	0.998	0.000
F70 Mild mental retardation	0.001	0.998	0.000
F98 Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.001	0.998	0.000
F95 Tic disorders	0.001	0.998	0.000
F94 Disorders of social functioning with onset specific to childhood and adolescence	0.001	0.998	0.000
F93 Emotional disorders with onset specific to childhood	0.001	0.998	0.000
F92 Mixed disorders of conduct and emotions	0.001	0.998	0.000
F91 Conduct disorders	0.001	0.998	0.000
F90 Hyperkinetic disorders	0.001	0.998	0.000
H20.1 Chronic iridocyclitis	0.001	0.998	0.000
I42.9 Cardiomyopathy, unspecified	0.000	0.998	0.002
K11.8 Other diseases of salivary glands	0.001	0.998	0.000
F50 Eating disorders	0.001	0.998	0.000
F79 Unspecified mental retardation	0.001	0.998	0.000
V49.81 Car occupant injured in trnsp accident w military vehicle (Car occupant (driver) (passenger) injured in transport accident with military vehicle)	0.001	0.998	0.000
J38.7 Other diseases of larynx	0.000	0.998	0.002
H15 Disorders of sclera	0.001	0.998	0.000
H18.6 Keratoconus	0.001	0.998	0.000
H20.8 Other iridocyclitis	0.001	0.998	0.000
F34.9 Persistent mood [affective] disorder, unspecified	0.001	0.998	0.000
F34.8 Other persistent mood [affective] disorders	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations